Effectively Managing Global Trials Within a CRO Alliance Structure
Track
:
Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code:
376
Date:
Wednesday, June 27, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
(S):
Michael O'Brien, Beardsworth Consulting Group Inc., United States
Mr O’Brien is Beardsworth’s President/CEO. Previous corporate roles in BD, strategic plng, technology, int’l finance/operations across biotech/medical device/CROs inc Bionx Implants, Biosyn Inc & Biocyte Corp (cord blood stem cells). Began career at Deloitte & Touche. Villanova University alum.
Dan Diaz, Beardsworth Consulting Group Inc., United States
Beardsworth VP Business Development; 25+ years industry experience. Expertise across all phases/entities of clinical research–government contracting, small/Global Pharma, Biotechs, niche CROs & SMOs. Leading Beardsworth’s complex/rescue/vaccine programs & OncologyOne® –for global business solutions.
PRESENTER
(S):
Dan Diaz, Beardsworth Consulting Group Inc., United States
Beardsworth VP Business Development; 25+ years industry experience. Expertise across all phases/entities of clinical research–government contracting, small/Global Pharma, Biotechs, niche CROs & SMOs. Leading Beardsworth’s complex/rescue/vaccine programs & OncologyOne® –for global business solutions.
Dr Malgorzata Szerszeniewska is a co-founder of EastHORN Clinical Services in CEE Ltd, where she serves as Chief Executive Officer. Previously, she was President of AbCRO, Inc., an American-owned CRO operating in Central and Eastern Europe (CEE) and over 10 years at Covance as CEE Global Director.
Alek Safarian is the CEO of Novotech, the largest Australian CRO, with operations across Australia, New Zealand and Asia. A registered pharmacist, and with a MBA from the University of Sydney, his extensive background in drug development spans both the Sponsor and CRO sides of the industry.
Description
This forum explores one key challenge confronting global alliances of regional CROs: aligning motivations and expectations of sponsor and alliance members to achieve an optimal multicultural, multinational result.
Learning Objectives: Identify common challenges and contradictions inherent in globalized CRO alliances Recognize how an affiliation of smaller or regional CROs can effectively compete for global opportunities Describe challenges and solutions for conducting a global study with Affiliate Partners.